Bottom line
EFA vs IDEV: the short answer
EFA (iShares MSCI EAFE ETF) and IDEV (iShares Core MSCI International Developed Markets ETF) have nearly the same top holdings — their top 25 positions are about 86% the same by weight.
But IDEV is far broader, holding 2,337 positions to 691 for EFA, so beyond the top names it adds exposure EFA doesn't have.
IDEV is cheaper at 0.04% vs 0.32% — a difference of $28 a year per $10,000 invested.
Over five years, IDEV returned +5.0% a year vs +4.7% for EFA.
Updated Nov 19, 2026
EFA vs IDEV side by side
| EFA | IDEV | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | iShares |
| Category | International Stock | International Stock |
| Expense ratio | 0.32% | 0.04% |
| Annual cost per $10k | $32 | $4 |
| 10-yr cost on $10k (prospectus) | $406 | $51 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +3.4% | +4.5% |
| 5-yr return (annualized) | +4.7% | +5.0% |
| 10-yr return (annualized) | +5.1% | — |
| Best quarter | +18.1% | +16.9% |
| Worst quarter | −22.9% | −24.0% |
| Net assets (fund) | $78.0B | $31.6B |
| Number of holdings | 691 | 2,337 |
| Portfolio turnover | 4% | 3% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | EFA | IDEV | Difference |
|---|---|---|---|
| 2024 | +3.4% | +4.5% | −1.1% |
| 2023 | +18.1% | +17.3% | +0.8% |
| 2022 | −14.3% | −14.9% | +0.7% |
| 2021 | +11.2% | +12.7% | −1.5% |
| 2020 | +7.9% | +8.4% | −0.5% |
| 2019 | +21.9% | +23.4% | −1.4% |
| 2018 | −13.8% | −14.3% | +0.5% |
Source: Fund prospectus bar charts
Holdings overlap
22 of EFA's top 25 holdings also appear in IDEV's top 25.
| Holding | EFA | IDEV |
|---|---|---|
| ASML Holding N.V. | 2.90% | 2.19% |
| Hsbc Holdings Plc | 1.66% | 1.24% |
| Roche Holding AG | 1.39% | 1.05% |
| Novartis AG | 1.30% | 0.98% |
| Nestle S.A. | 1.17% | 0.88% |
| Shell Plc | 1.17% | 0.88% |
| Astrazeneca Plc | 1.17% | 0.88% |
| Siemens Aktiengesellschaft | 1.10% | 0.83% |
| Mitsubishi UFJ Financial Group, Inc. | 1.08% | 0.82% |
| Bhp Group Limited | 0.97% | 0.73% |
| Commonwealth Bank Of Australia | 0.95% | 0.72% |
| Banco Santander, S.A. | 0.93% | 0.70% |
| Sap Se | 0.87% | 0.65% |
| Allianz SE | 0.86% | 0.65% |
| Schneider Electric Se | 0.84% | 0.63% |
Source: SEC Form N-PORT
EFA top 10
- ASML Holding N.V. — 2.90%
- Hsbc Holdings Plc — 1.66%
- Roche Holding AG — 1.39%
- Novartis AG — 1.30%
- Nestle S.A. — 1.17%
- Shell Plc — 1.17%
- Astrazeneca Plc — 1.17%
- Siemens Aktiengesellschaft — 1.10%
- Mitsubishi UFJ Financial Group, Inc. — 1.08%
- Bhp Group Limited — 0.97%
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
FAQ
What is the difference between EFA and IDEV?
Which is cheaper, EFA or IDEV?
Should I own both EFA and IDEV?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.